TLX · ISSUER CIK 2007191
Telix Pharmaceuticals Ltd
Between Aug 1, 2026 and Oct 29, 2026, 1 Telix Pharmaceuticals Ltd insiders reported $20K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Smith Darren Charlton (Group Chief Financial Officer), with $20K.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$20KInsider buying
$0.00Insider selling
+$20KNet open-market
Sep 14, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 202619:20 | Sep 7, 2026 | TLX | Group Chief Financial Officer | P · BuyLate 7d | $9.66 | +2,071 | 13,992 | +17% | +$20K | -22.3% | -1.5% |